Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-02-22 STOLICK DAVID Chief Financial Officer Sale −100,000 $0.36 $36K 150,000
2010-02-17 STOLICK DAVID Chief Financial Officer Sale −2,000 $0.36 $720 250,000
2010-02-16 STOLICK DAVID Chief Financial Officer Sale −3,000 $0.36 $1K 392,000
2010-02-16 STOLICK DAVID Chief Financial Officer Sale −140,000 $0.36 $50K 252,000
2010-02-12 STOLICK DAVID Chief Financial Officer Sale −5,000 $0.36 $2K 395,000
2010-02-12 STOLICK DAVID Chief Financial Officer Exercise or conversion · Stock Option (right to buy) +400,000 0
2009-06-29 STOLICK DAVID Chief Financial Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2007-03-21 STOLICK DAVID Chief Financial Officer Grant or award · Stock Option (right to buy) +350,000 350,000
2006-05-02 STOLICK DAVID Chief Financial Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2006-02-06 STOLICK DAVID Chief Financial Officer Returned to the company · Stock Option (right to buy) −400,000 0
2006-02-06 STOLICK DAVID Chief Financial Officer Grant or award · Stock Option (right to buy) +400,000 400,000
2005-03-29 STOLICK DAVID Chief Financial Officer Grant or award · Stock Option (right to buy) +400,000 400,000

Page 1 of 1 · 12 trades